Compound X21 (CYP19A1/CYP11B2-IN-1) is a potent dual inhibitor of aromatase (CYP19A1) and aldosterone synthase (CYP11B2), with IC50 values of 2.3 nM and 29 nM, respectively. It exhibits strong antiproliferative and pro-apoptotic effects on cancer cells. Compound X21 is suitable for breast cancer research purposes [1].
Molecular Weight:
213.24
CAS Number:
[183500-36-9]
Formula:
C12H11N3O
Target:
Cytochromes P450
T86150
* VAT and and shipping costs not included. Errors and price changes excepted